Cargando…

Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma

BACKGROUND: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponschab, Martin, Voelckel, Wolfgang, Pavelka, Michaela, Schlimp, Christoph J., Schöchl, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625604/
https://www.ncbi.nlm.nih.gov/pubmed/26514413
http://dx.doi.org/10.1186/s13049-015-0165-4
_version_ 1782398004352778240
author Ponschab, Martin
Voelckel, Wolfgang
Pavelka, Michaela
Schlimp, Christoph J.
Schöchl, Herbert
author_facet Ponschab, Martin
Voelckel, Wolfgang
Pavelka, Michaela
Schlimp, Christoph J.
Schöchl, Herbert
author_sort Ponschab, Martin
collection PubMed
description BACKGROUND: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC has not been adequately investigated. METHODS: In this retrospective observational study, changes to ROTEM parameters, induced by three different therapeutic interventions, were investigated: patients receiving FC only (FC-group); patients treated with FC and PCC (FC + PCC-group) and patients treated with PCC only (PCC-group). RESULTS: The study population comprised 96 patients who were predominately male (69 [71.9 %]), median age was 45.0 (26.3–60.0) years, and the median injury severity score was 34.0 (25.0–44.5). Administration of FC resulted in a significant reduction of the clotting time (CT) in both the EXTEM and FIBTEM assays but had no effect on INTEM CT. Clot amplitude (CA) increased significantly in the FIBTEM assay but remained unchanged in the EXTEM and INTEM assays. The combined administration of FC and PCC increased FIBTEM maximum clot firmness (MCF) and normalized EXTEM CT but did not change either INTEM or FIBTEM CT. Following PCC therapy, EXTEM and FIBTEM CT normalized; CA at 10 min after CT measurements decreased significantly in EXTEM, INTEM and FIBTEM. CONCLUSIONS: Administration of FC alone or in combination with PCC resulted in a significant improvement of fibrin polymerisation as measured by an increase in FIBTEM MCF. CT is dependent not only on thrombin generation but also on the availability of substrate (fibrinogen). Accelerated fibrin polymerisation rate results in earlier clot formation and consequently shorter CT. PCC administration normalised EXTEM CT below the upper threshold of 80 s. This study was performed at the AUVA Trauma Centre Salzburg, Salzburg, Austria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13049-015-0165-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4625604
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46256042015-10-30 Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma Ponschab, Martin Voelckel, Wolfgang Pavelka, Michaela Schlimp, Christoph J. Schöchl, Herbert Scand J Trauma Resusc Emerg Med Original Research BACKGROUND: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC has not been adequately investigated. METHODS: In this retrospective observational study, changes to ROTEM parameters, induced by three different therapeutic interventions, were investigated: patients receiving FC only (FC-group); patients treated with FC and PCC (FC + PCC-group) and patients treated with PCC only (PCC-group). RESULTS: The study population comprised 96 patients who were predominately male (69 [71.9 %]), median age was 45.0 (26.3–60.0) years, and the median injury severity score was 34.0 (25.0–44.5). Administration of FC resulted in a significant reduction of the clotting time (CT) in both the EXTEM and FIBTEM assays but had no effect on INTEM CT. Clot amplitude (CA) increased significantly in the FIBTEM assay but remained unchanged in the EXTEM and INTEM assays. The combined administration of FC and PCC increased FIBTEM maximum clot firmness (MCF) and normalized EXTEM CT but did not change either INTEM or FIBTEM CT. Following PCC therapy, EXTEM and FIBTEM CT normalized; CA at 10 min after CT measurements decreased significantly in EXTEM, INTEM and FIBTEM. CONCLUSIONS: Administration of FC alone or in combination with PCC resulted in a significant improvement of fibrin polymerisation as measured by an increase in FIBTEM MCF. CT is dependent not only on thrombin generation but also on the availability of substrate (fibrinogen). Accelerated fibrin polymerisation rate results in earlier clot formation and consequently shorter CT. PCC administration normalised EXTEM CT below the upper threshold of 80 s. This study was performed at the AUVA Trauma Centre Salzburg, Salzburg, Austria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13049-015-0165-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-29 /pmc/articles/PMC4625604/ /pubmed/26514413 http://dx.doi.org/10.1186/s13049-015-0165-4 Text en © Ponschab et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research
Ponschab, Martin
Voelckel, Wolfgang
Pavelka, Michaela
Schlimp, Christoph J.
Schöchl, Herbert
Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
title Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
title_full Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
title_fullStr Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
title_full_unstemmed Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
title_short Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
title_sort effect of coagulation factor concentrate administration on rotem® parameters in major trauma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625604/
https://www.ncbi.nlm.nih.gov/pubmed/26514413
http://dx.doi.org/10.1186/s13049-015-0165-4
work_keys_str_mv AT ponschabmartin effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma
AT voelckelwolfgang effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma
AT pavelkamichaela effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma
AT schlimpchristophj effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma
AT schochlherbert effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma